Loading…
Loading…
SGRY does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for SGRY and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for SGRY and 80,000+ other tickers.
See exactly how SGRY's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for SGRY and 80,000+ other tickers.
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging…
On October 6, 2026, Larry Robbins (Trades, Portfolio) of Glenview Capital Management initiated a new position in Surgery Partners Inc (SGRY), acquiring 7,023,33
Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
I initiate coverage of Surgery Partners with a Buy, citing positives relating to the Idaho Falls divestiture. SGRY's asset sale reduces leverage, improves cash flow, and shifts payor mix away from Medicaid. That also simplifies its business and boosts its valuation appeal as a short-stay surgical pure-play. I see significant upside from the $60B inpatient-to-outpatient migration, supported by robust practitioner recruitment and disciplined acquisition strategy.
BRENTWOOD, Tenn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced it has completed the previously announced sale of its ownership interests in its Idaho Falls facilities to Intermountain Health.
The purchase was valued at approximately $161,000. DeLuca's total position now consists of 68,093 shares.